Comparison of quality of life and arm complaints after axillary lymph node dissection vs sentinel lymph node biopsy in breast cancer patients

F Peintinger, R Reitsamer, H Stranzl, G Ralph, F Peintinger, R Reitsamer, H Stranzl, G Ralph

Abstract

The sentinel lymph node biopsy (SLNB) represents a minimal invasive surgical method for axillary staging in patients with primary breast cancer. In a prospective study, evaluation of quality of life (QOL) and arm morbidity was performed before surgery on a total of 56 breast cancer patients. The EORTC QLQ-C30 and EORTC QLQ-BR23 questionnaires were used for QOL assessment. Assessment of pain was additionally observed using the McGill Pain Questionnaire. Arm mobility was observed by goniometric measurement of arm movement. Data were collected before surgery (t1), 1 week after discharge (t2) and 9-12 months after surgery (t3). The type of axillary surgery does not seem to affect global QOL at a short-time follow-up, but patients recover sooner after SLNB. Body image and sexual functioning remain stable in both types of axillary surgery. Arm/shoulder pain was reported in 36% of patients after SLNB in comparison to 68% receiving axillary lymph node dissection (ALND), and 'numbness' was reported only in 4% of patients in the SLNB group vs 19.3% after ALND. Abduction, flexion and horizontal adduction of the affected arm show significant impairment after ALND. Breast cancer patients should be counselled about the benefits of SLNB over ALND concerning QOL and postsurgery side effects in a short-term follow-up.

Figures

Figure 1
Figure 1
Comparison of global QOL (means) after ANLD vs SLNB over time.
Figure 2
Figure 2
Comparison of pain (means) after ALND vs SLNB over time.

References

    1. Aaronson NK, Ahmedzai S, Bergman B, Bullinger M, Cull A, Duez N, Filiberti A, Flechtner H, Fleishman SB, de Haes JC, Kaasa S, Klee M, Osoba D, Razavi D, Rofe PB, Schraub S, Sneeuw K, Sullivan M, Takeda F, for the European Organization for Research Treatment of Cancer Study Group on Quality of Life (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85: 365–376
    1. Burak WE, Hollenbeck ST, Zervos EE, Hock KL, Kemp LC, Young DC (2002) Sentinel lymph node biopsy results in less postoperative morbidity compared with axillary lymph node dissection for breast cancer. Am J Surg 183: 23–27
    1. Carter CL, Allen C, Henson DE (1989) Relation of tumor size, lymph node status and survival in 24,740 breast cancer cases. Cancer 63: 181–187
    1. Coscarelli Schag CA, Ganz PA, Polinsky ML, Fred C, Hirji K, Petersen L (1993) Characteristics of women at risk for psychosocial distress in the year after breast cancer. J Clin Oncol 11: 783–793
    1. Fallowfield LJ, Baum M, Maguire GP (1986) Effects of breast conservation on psychological morbidity associated with diagnosis and treatment of early breast cancer. Br Med J 293: 1331–1334
    1. Fayers PM, Aaronson NK, Bjordal K, Curran D, Groenvold M (1999) The EORTC QLQ-C30 Scoring Manual, 2nd edn. Brussels: European Organization for Research and Treatment of Cancer, Pamphlet
    1. Fisher ER, Sass R, Fisher B (1984) Pathologic findings from the National Surgical Adjuvant Project for Breast Cancers (Protocol No. 4). Cancer 53: 712–723
    1. Ganz PA, Schag CAC, Lee JJ, Polinsky ML, Tan SJ (1992) Breast conservation versus mastectomy. Is there a difference in psychological adjustment or quality of life in the year after surgery? Cancer 69: 1729–1738
    1. Giuliano AE, Haigh PI, Brennan MB, Hansen NM, Kelley MC, Ye W, Glass EC, Turner RR (2000) Prospective observational study of sentinel lymphadenectomy without further axillary dissection in patients with sentinel node-negative breast cancer. J Clin Oncol 18: 2553–2559
    1. Hack TF, Cohen L, Katz J, Robson L, Goss P (1999) Physical and psychological morbidity after axillary lymph node dissection for breast cancer. J Clin Oncol 17: 143–149
    1. Haid A, Koberle-Wuhrer R, Knauer M, Burtscher J, Fritzsche H, Peschina W, Jasarevic Z, Ammann M, Hergan K, Sturn H, Zimmermann G (2002) Morbidity of breast cancer patients following complete axillary dissection or sentinel node biopsy only: a comparative evaluation. Breast Cancer Res Treat 73: 31–36
    1. Ivens D, Hoe AL, Podd TJ, Hamilton CR, Taylor I, Royle GT (1992) Assessment of morbidity from complete axillary dissection. Br J Cancer 66: 136–138
    1. Janni W, Rjosk D, Dimpfl T, Haertl K, Strobl B, Hepp F, Hanke A, Bergauer F, Sommer H (2001) Quality of life influenced by primary surgical treatment for stage I–III breast cancer – Long-term follow-up of a matched-pair analysis. Ann Surg Oncol 8: 542–548
    1. Kakuda JT, Stuntz M, Trivedi V, Klein SR, Vargas HI (1999) Objective assessment of axillary morbidity in breast cancer treatment. Am Surgeon 65: 995–998
    1. Keramopoulos A, Tsionou C, Minaretzis D, Michalas S, Aravantinos D (1993) Arm morbidity following treatment of breast cancer with total axillary dissection: a multivariated approach. Oncology 50: 445–449
    1. Kissin MW, Querci della Rovere G, Easton D, Westbury G (1986) Risk of lympoedema following the treatment of breast cancer. Br J Surg 73: 580–584
    1. Kuehn T, Klauss W, Darsow M, regele S, Flock F, Maiterth C, Dahlbender R, Wendt I, Kreienberg R (2000) Long-term morbidity following axillary dissection in breast cancer patients – clinical assessment, significance for life quality and the impact of demographic, oncologic and therapeutic factors. Breast Cancer Res Treat 64: 275–286
    1. Maunsell E, Brisson J, Deschenes L (1993) Arm problems and psychological distress after surgery for breast cancer. Can J Surg 36: 315–320
    1. Melzack R (1975) The McGill pain questionnaire: major properties and scoring methods. Pain 1: 277–299
    1. Reitsamer R, Peintinger F, Prokop E, Menzel C, Cimpoca W, Rettenbacher L (2003) Sentinel lymph node biopsy alone without axillary lymph node dissection – follow up of sentinel lymph node negative breast cancer patients. Eur J Surg Oncol 29: 221–223
    1. Schrenk P, Rieger R, Shamiyeh A, Wayand W (2000) Morbidity following sentinel lymph node biopsy versus axillary lymph node dissection for patients with breast carcinoma. Cancer 88: 608–614
    1. Shimozuma K, Ganz PA, Petersen L, Hirji K (1999) Quality of life in the first year after breast cancer surgery: rehabilitation needs and patterns of recovery. Breast Cancer Res Treat 56: 45–57
    1. Stein C, Mendl G (1988) The German counterpart to McGill pain questionnaire. Pain 32: 251–255
    1. Temple LK, Baron R, Cody HS, Fey JV, Thaler HAT, Borgen PI, Heerdt AS, montgomery LL, Petrek JA, Van Zee KJ (2002) Sensory morbidity after sentinel lymph node biopsy and axillary dissection: a prospective study of 233 women. Ann Surg Oncol 9: 654–662
    1. Tobin MB, Lacey HJ, Meyer L, Mortimer PS (1993) The psychological morbidity of breast cancer-related arm swelling. Psychological morbidity of lymphoedema. Cancer 72: 3248–3252
    1. Van Dam MS, Hennipman A, de Kruif JT, van der Tweel I, de Graaf PW (1993) Complications following axillary dissection for breast carcinoma. Ned Tijdschr Geneesk 137: 2395–2398
    1. Ververs JM, Roumen RM, Vingerhoets AJ, Veugdenhil G, Coebergh JW, Crommelin MA, Luiten EJ, Repelaer van Driel OJ, Schijven M, Wissing JC, Voogd AC (2001) Risk, severity and predictors of physical and psychological morbidity after axillary lymph node dissection for breast cancer. Eur J Cancer 37: 991–999

Source: PubMed

Sponsorer och medarbetare

Medicinska tillstånd

Läkemedelsinterventioner

3
Prenumerera